Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of teriflunomide added to interferon-beta in multiple sclerosis
2006-003134-14Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of teriflunomide in multiple sclerosis (MS) (3 arms), sponsored by Sanofi. Primary endpoints: Safety and tolerability, Pharmacokinetics of teriflunomide and 1 more. Started Feb 2007; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-003134-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003134-14.